Calcineurin Inhibitor Immunosuppressant [EPC]

Calcineurin Inhibitor Immunosuppressant [EPC] was reported 130452 times

Drugs of the Calcineurin Inhibitor Immunosuppressant [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 LYMPHOID TISSUE HYPOPLASIA 97 0.6340
1 THYMUS HYPOPLASIA 96 0.5517
2 CYTOMEGALOVIRUS ANTIGEN POSITIVE 84 0.4590
3 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 101 0.4262
4 RED BLOOD CELL SEDIMENTATION RATE 107 0.3835
5 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1040 0.3759
6 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 92 0.3755
7 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 269 0.3741
8 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 526 0.3723
9 GRAFT DYSFUNCTION 99 0.3474
10 CHRONIC GRAFT VERSUS HOST DISEASE 1214 0.3359
11 TRANSPLANT DYSFUNCTION 591 0.3309
12 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 113 0.3104
13 CYSTITIS VIRAL 117 0.3055
14 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 639 0.3000
15 ENCEPHALITIS CYTOMEGALOVIRUS 130 0.2968
16 VIRAL HAEMORRHAGIC CYSTITIS 211 0.2963
17 GRAFT VERSUS HOST DISEASE IN LIVER 205 0.2863
18 GRANULOMA SKIN 235 0.2862
19 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 265 0.2862
20 ACUTE GRAFT VERSUS HOST DISEASE 1306 0.2850
21 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 367 0.2787
22 GRAFT VERSUS HOST DISEASE IN SKIN 592 0.2685
23 PRODUCT DROPPER ISSUE 202 0.2567
24 SMOOTH MUSCLE CELL NEOPLASM 107 0.2560
25 CYTOMEGALOVIRUS INFECTION REACTIVATION 1116 0.2524
26 BK VIRUS INFECTION 848 0.2512
27 SCLERAL HYPERAEMIA 168 0.2467
28 GRAFT VERSUS HOST DISEASE 1744 0.2423
29 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 388 0.2193
30 KAPOSI'S SARCOMA 109 0.2171
31 CHRONIC ALLOGRAFT NEPHROPATHY 167 0.2133
32 LYMPHOCELE 140 0.2108
33 EPSTEIN-BARR VIRAEMIA 229 0.2065
34 DISSEMINATED ASPERGILLOSIS 97 0.2055
35 BLOOD PARATHYROID HORMONE DECREASED 281 0.1895
36 FOREIGN BODY SENSATION IN EYES 1184 0.1856
37 ADENOVIRUS INFECTION 536 0.1846
38 EYE IRRITATION 10627 0.1844
39 CHRONIC SPONTANEOUS URTICARIA 205 0.1767
40 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 894 0.1755
41 HEART TRANSPLANT REJECTION 182 0.1753
42 ASPERGILLOSIS 229 0.1752
43 KIDNEY TRANSPLANT REJECTION 818 0.1703
44 EPSTEIN-BARR VIRUS INFECTION 1051 0.1681
45 GINGIVAL HYPERTROPHY 249 0.1640
46 TRANSPLANT REJECTION 1311 0.1635
47 ENGRAFTMENT SYNDROME 95 0.1607
48 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 125 0.1598
49 CYTOMEGALOVIRUS VIRAEMIA 690 0.1550
50 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 181 0.1508
51 OBLITERATIVE BRONCHIOLITIS 197 0.1500
52 COMPLICATIONS OF TRANSPLANTED KIDNEY 338 0.1489
53 CYSTITIS HAEMORRHAGIC 598 0.1482
54 POLYOMAVIRUS VIRAEMIA 156 0.1469
55 PNEUMONIA CYTOMEGALOVIRAL 284 0.1461
56 SUPERFICIAL INJURY OF EYE 159 0.1455
57 LUNG TRANSPLANT REJECTION 95 0.1439
58 INSTILLATION SITE IRRITATION 167 0.1410
59 LIVER TRANSPLANT REJECTION 253 0.1407
60 CYTOMEGALOVIRUS INFECTION 2332 0.1402
61 INSTILLATION SITE PAIN 346 0.1395
62 PARVOVIRUS B19 INFECTION 123 0.1374
63 MULTIPLE USE OF SINGLE-USE PRODUCT 743 0.1322
64 HUMAN HERPESVIRUS 6 INFECTION 248 0.1311
65 PANNICULITIS 309 0.1276
66 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 420 0.1270
67 CEREBRAL TOXOPLASMOSIS 118 0.1263
68 VIRAEMIA 174 0.1255
69 TRANSPLANT FAILURE 305 0.1243
70 APLASTIC ANAEMIA 620 0.1186
71 RENAL TUBULAR ATROPHY 102 0.1156
72 PRODUCT CONTAINER ISSUE 965 0.1124
73 THROMBOTIC MICROANGIOPATHY 1078 0.1105
74 ACUTE MYELOID LEUKAEMIA RECURRENT 233 0.1084
75 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 248 0.1058
76 ENTHESOPATHY 165 0.1054
77 VENOOCCLUSIVE DISEASE 262 0.1045
78 EYELID PAIN 212 0.1042
79 ERYTHRODERMIC PSORIASIS 84 0.1019
80 ENCEPHALITIS VIRAL 124 0.1018
81 BLOOD IRON ABNORMAL 98 0.1003
82 RHEUMATOID NODULE 276 0.1001
83 STEROID DEPENDENCE 87 0.0991
84 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 158 0.0986
85 SOFT TISSUE DISORDER 109 0.0983
86 NEPHROPATHY TOXIC 1066 0.0949
87 CYTOMEGALOVIRUS TEST POSITIVE 169 0.0947
88 KIDNEY FIBROSIS 157 0.0904
89 VENOOCCLUSIVE LIVER DISEASE 446 0.0902
90 CYTOMEGALOVIRUS COLITIS 207 0.0899
91 PSEUDOMONAL SEPSIS 155 0.0884
92 EYE PAIN 4936 0.0874
93 SYSTEMIC MYCOSIS 100 0.0856
94 JC VIRUS INFECTION 136 0.0850
95 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 636 0.0847
96 EYE DISCHARGE 867 0.0834
97 CYTOMEGALOVIRUS CHORIORETINITIS 161 0.0825
98 TOXOPLASMOSIS 87 0.0806
99 LYMPHOPROLIFERATIVE DISORDER 236 0.0803
100 LUPUS NEPHRITIS 149 0.0796
101 LEUKAEMIA RECURRENT 134 0.0792
102 OCULAR DISCOMFORT 890 0.0792
103 PRODUCT PACKAGING DIFFICULT TO OPEN 206 0.0789
104 HISTIOCYTOSIS HAEMATOPHAGIC 232 0.0781
105 BRONCHOPULMONARY ASPERGILLOSIS 602 0.0776
106 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 737 0.0771
107 STENOTROPHOMONAS INFECTION 103 0.0759
108 ALANINE AMINOTRANSFERASE ABNORMAL 160 0.0758
109 RENAL TUBULAR INJURY 92 0.0757
110 HIRSUTISM 98 0.0737
111 EYELID IRRITATION 185 0.0737
112 DRUG TOLERANCE DECREASED 201 0.0715
113 VARICELLA ZOSTER VIRUS INFECTION 148 0.0713
114 ENTEROBACTER INFECTION 119 0.0707
115 ABNORMAL SENSATION IN EYE 303 0.0704
116 PNEUMOCYSTIS JIROVECI PNEUMONIA 156 0.0700
117 SECONDARY IMMUNODEFICIENCY 84 0.0691
118 ENTEROCOCCAL INFECTION 333 0.0688
119 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 179 0.0672
120 APLASIA PURE RED CELL 225 0.0653
121 SKIN NECROSIS 338 0.0651
122 CORNEAL ABRASION 89 0.0649
123 MUCORMYCOSIS 168 0.0646
124 OCULAR HYPERAEMIA 3060 0.0644
125 STEM CELL TRANSPLANT 159 0.0636
126 ASPERGILLUS INFECTION 413 0.0629
127 TENOSYNOVITIS 172 0.0623
128 LACRIMATION INCREASED 1872 0.0619
129 NOCARDIOSIS 157 0.0613
130 CUSHINGOID 195 0.0607
131 PSEUDOMONAS INFECTION 516 0.0601
132 HAEMOLYTIC URAEMIC SYNDROME 139 0.0599
133 ERYTHEMA OF EYELID 324 0.0598
134 HYPOGAMMAGLOBULINAEMIA 390 0.0593
135 CONCOMITANT DISEASE PROGRESSION 115 0.0588
136 BACTERIAL SEPSIS 191 0.0586
137 KLEBSIELLA INFECTION 295 0.0583
138 C-REACTIVE PROTEIN ABNORMAL 371 0.0578
139 PROTEINURIA 1079 0.0567
140 HYPERTRICHOSIS 105 0.0566
141 NEPHROTIC SYNDROME 388 0.0565
142 PNEUMOMEDIASTINUM 97 0.0536
143 PNEUMATOSIS INTESTINALIS 153 0.0536
144 SYSTEMIC CANDIDA 134 0.0533
145 EYE PRURITUS 1755 0.0522
146 STAPHYLOCOCCAL BACTERAEMIA 227 0.0522
147 DRY EYE 2589 0.0518
148 PYODERMA GANGRENOSUM 186 0.0517
149 PNEUMONIA KLEBSIELLA 95 0.0516
150 PNEUMONIA VIRAL 162 0.0508
151 HERPES SIMPLEX 322 0.0495
152 STAPHYLOCOCCAL SEPSIS 243 0.0492
153 PNEUMONIA FUNGAL 194 0.0491
154 OVARIAN CYST 481 0.0481
155 APLASIA 94 0.0480
156 BRAIN ABSCESS 117 0.0462
157 LEUKOENCEPHALOPATHY 169 0.0453
158 BONE MARROW TRANSPLANT 86 0.0453
159 EYELID MARGIN CRUSTING 131 0.0453
160 RED BLOOD CELL SEDIMENTATION RATE INCREASED 498 0.0450
161 ASTHENOPIA 236 0.0429
162 PNEUMOCYSTIS JIROVECII PNEUMONIA 430 0.0428
163 PUSTULAR PSORIASIS 147 0.0428
164 GLOMERULAR FILTRATION RATE DECREASED 523 0.0425
165 GLOMERULONEPHRITIS 104 0.0424
166 SERUM FERRITIN INCREASED 224 0.0424
167 ESCHERICHIA SEPSIS 123 0.0424
168 THROMBOTIC THROMBOCYTOPENIC PURPURA 149 0.0422
169 SWELLING OF EYELID 265 0.0422
170 CAPILLARY LEAK SYNDROME 87 0.0420
171 PRODUCT DELIVERY MECHANISM ISSUE 220 0.0409
172 ACTINIC KERATOSIS 105 0.0404
173 GROWTH RETARDATION 119 0.0404
174 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 104 0.0403
175 PHOTOPHOBIA 742 0.0394
176 BASAL CELL CARCINOMA 611 0.0391
177 EYELID DISORDER 90 0.0390
178 GRANULOMA 135 0.0390
179 BACTERAEMIA 454 0.0382
180 AUTOIMMUNE HAEMOLYTIC ANAEMIA 131 0.0382
181 MUCOSAL INFLAMMATION 991 0.0378
182 DEMYELINATION 154 0.0375
183 SYNOVITIS 675 0.0374
184 SCLERODERMA 136 0.0374
185 EYELIDS PRURITUS 116 0.0372
186 BLOOD CREATININE INCREASED 2357 0.0361
187 HEPATOSPLENOMEGALY 91 0.0354
188 HAEMODIALYSIS 296 0.0352
189 MULTI-ORGAN FAILURE 604 0.0349
190 BACTERIAL INFECTION 651 0.0349
191 SKIN PLAQUE 294 0.0348
192 DRUG ERUPTION 617 0.0348
193 SERUM SICKNESS 97 0.0348
194 RHINOVIRUS INFECTION 134 0.0344
195 ESCHERICHIA INFECTION 280 0.0340
196 HAEMOLYSIS 262 0.0339
197 HYPERCALCAEMIA 418 0.0338
198 CANDIDIASIS 135 0.0336
199 EYE INFLAMMATION 321 0.0336
200 MULTIPLE ORGAN DYSFUNCTION SYNDROME 948 0.0334
201 RENAL TRANSPLANT 119 0.0329
202 SQUAMOUS CELL CARCINOMA 309 0.0328
203 CLOSTRIDIUM DIFFICILE COLITIS 340 0.0320
204 BLEPHARITIS 127 0.0316
205 SQUAMOUS CELL CARCINOMA OF SKIN 191 0.0316
206 RENAL TUBULAR NECROSIS 308 0.0314
207 RENAL TUBULAR DISORDER 88 0.0312
208 IMMUNE THROMBOCYTOPENIA 141 0.0308
209 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 253 0.0306
210 KERATITIS 93 0.0306
211 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 198 0.0305
212 PROTEIN URINE PRESENT 151 0.0303
213 RHEUMATOID FACTOR POSITIVE 174 0.0301
214 BLOOD LACTATE DEHYDROGENASE INCREASED 469 0.0296
215 DIFFUSE LARGE B-CELL LYMPHOMA 227 0.0294
216 RENAL IMPAIRMENT 2475 0.0294
217 DERMATITIS EXFOLIATIVE GENERALISED 102 0.0293
218 PULMONARY ALVEOLAR HAEMORRHAGE 164 0.0292
219 LUNG INFILTRATION 258 0.0292
220 PNEUMONIA BACTERIAL 266 0.0290
221 B-CELL LYMPHOMA 98 0.0288
222 HEPATIC FIBROSIS 99 0.0288
223 C-REACTIVE PROTEIN INCREASED 1033 0.0284
224 DRUG TOLERANCE 142 0.0280
225 THERAPY PARTIAL RESPONDER 437 0.0280
226 ESCHERICHIA URINARY TRACT INFECTION 118 0.0277
227 RENAL FAILURE CHRONIC 213 0.0277
228 MYOPATHY 238 0.0275
229 EYE INFECTION 311 0.0275
230 EYE SWELLING 1009 0.0271
231 EYELID OEDEMA 314 0.0270
232 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 103 0.0269
233 HYPERURICAEMIA 110 0.0267
234 CONTRAINDICATED PRODUCT ADMINISTERED 810 0.0267
235 PYELONEPHRITIS 231 0.0266
236 OLIGURIA 165 0.0266
237 HEPATITIS B 158 0.0262
238 PULMONARY TUBERCULOSIS 111 0.0260
239 SEPTIC SHOCK 1125 0.0258
240 HYPOALBUMINAEMIA 201 0.0258
241 VISION BLURRED 3510 0.0255
242 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1401 0.0255
243 ACUTE RESPIRATORY DISTRESS SYNDROME 445 0.0251
244 ULCER 400 0.0251
245 DRUG LEVEL INCREASED 414 0.0250
246 ENCEPHALITIS 172 0.0248
247 INTRACRANIAL PRESSURE INCREASED 138 0.0247
248 THERAPY NON-RESPONDER 1109 0.0246
249 LYMPHOPENIA 348 0.0246
250 IMMUNOSUPPRESSION 214 0.0242
251 BLOOD UREA INCREASED 406 0.0242
252 BLOOD BILIRUBIN INCREASED 653 0.0241
253 PANCYTOPENIA 1349 0.0241
254 GUILLAIN-BARRE SYNDROME 116 0.0240
255 URINE ABNORMALITY 109 0.0240
256 LIVER TRANSPLANT 87 0.0239
257 OESOPHAGEAL CANDIDIASIS 95 0.0238
258 BONE EROSION 84 0.0237
259 HYPERBILIRUBINAEMIA 246 0.0237
260 TREATMENT FAILURE 1966 0.0237
261 HERPES VIRUS INFECTION 136 0.0236
262 SKIN PAPILLOMA 94 0.0234
263 TONGUE DISORDER 169 0.0233
264 AZOTAEMIA 93 0.0233
265 BLOOD CREATINE INCREASED 103 0.0232
266 BONE MARROW FAILURE 472 0.0232
267 ENDOCARDITIS 119 0.0232
268 PULMONARY HAEMORRHAGE 181 0.0231
269 DRUG RESISTANCE 593 0.0231
270 DISSEMINATED INTRAVASCULAR COAGULATION 325 0.0231
271 NEUROTOXICITY 404 0.0230
272 HEPATIC FUNCTION ABNORMAL 855 0.0229
273 HAEMOLYTIC ANAEMIA 205 0.0229
274 ANURIA 195 0.0226
275 GENERALISED OEDEMA 279 0.0225
276 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 160 0.0223
277 STREPTOCOCCAL INFECTION 124 0.0223
278 CONCOMITANT DISEASE AGGRAVATED 135 0.0219
279 HORDEOLUM 94 0.0217
280 BRONCHIECTASIS 145 0.0215
281 SKIN ULCER 555 0.0214
282 URINE OUTPUT DECREASED 186 0.0213
283 SKIN LESION 581 0.0212
284 BLOOD URIC ACID INCREASED 122 0.0211
285 PERIORBITAL SWELLING 119 0.0210
286 CYTOPENIA 256 0.0209
287 FUNGAL INFECTION 696 0.0209
288 CANDIDA INFECTION 352 0.0208
289 PSORIATIC ARTHROPATHY 837 0.0206
290 STAPHYLOCOCCAL INFECTION 680 0.0206
291 SPLENOMEGALY 240 0.0205
292 DRUG INTOLERANCE 1979 0.0205
293 NECROSIS 114 0.0205
294 LOW BIRTH WEIGHT BABY 162 0.0204
295 LEUKOPENIA 1013 0.0202
296 ORGANISING PNEUMONIA 100 0.0202
297 BLOOD PRESSURE DIASTOLIC INCREASED 93 0.0201
298 BREATH SOUNDS ABNORMAL 99 0.0201
299 SEPSIS 2228 0.0200
300 SKIN MASS 133 0.0199
301 DYSLIPIDAEMIA 100 0.0197
302 HYDRONEPHROSIS 146 0.0195
303 PAPILLOEDEMA 88 0.0195
304 LIVER FUNCTION TEST ABNORMAL 564 0.0194
305 SKIN INFECTION 215 0.0191
306 TOXIC ENCEPHALOPATHY 97 0.0191
307 RENAL FAILURE ACUTE 809 0.0190
308 PIGMENTATION DISORDER 117 0.0189
309 PRODUCT USE COMPLAINT 297 0.0188
310 ACUTE MYELOID LEUKAEMIA 293 0.0188
311 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 192 0.0187
312 CACHEXIA 96 0.0186
313 CHOLANGITIS 114 0.0184
314 DISEASE RECURRENCE 873 0.0183
315 THERAPY INTERRUPTED 1309 0.0183
316 HERPES ZOSTER 1052 0.0183
317 PRODUCT USE IN UNAPPROVED INDICATION 4531 0.0183
318 HYPERCHOLESTEROLAEMIA 176 0.0182
319 BRAIN OEDEMA 230 0.0182
320 VITREOUS FLOATERS 178 0.0181
321 PATHOGEN RESISTANCE 165 0.0181
322 INCORRECT PRODUCT STORAGE 237 0.0180
323 MYASTHENIA GRAVIS 145 0.0179
324 BLOOD ALBUMIN DECREASED 142 0.0179
325 HEPATIC ENZYME ABNORMAL 89 0.0178
326 TENDERNESS 185 0.0177
327 FEBRILE NEUTROPENIA 1176 0.0177
328 MYELODYSPLASTIC SYNDROME 256 0.0177
329 ALANINE AMINOTRANSFERASE INCREASED 1083 0.0176
330 INFLAMMATION 909 0.0176
331 ASPARTATE AMINOTRANSFERASE INCREASED 932 0.0175
332 ACUTE PULMONARY OEDEMA 98 0.0174
333 MALABSORPTION 91 0.0174
334 HEPATOTOXICITY 388 0.0174
335 RENAL CELL CARCINOMA 85 0.0174
336 THERAPEUTIC PRODUCT EFFECT DECREASED 777 0.0173
337 CHOLESTASIS 333 0.0173
338 RESPIRATORY FAILURE 1264 0.0173
339 DRUG LEVEL DECREASED 176 0.0173
340 COVID-19 PNEUMONIA 204 0.0173
341 REBOUND EFFECT 194 0.0171
342 HEPATITIS C 207 0.0171
343 PRE-EXISTING CONDITION IMPROVED 107 0.0171
344 EYE DISORDER 563 0.0171
345 NEPHROPATHY 159 0.0170
346 TRANSAMINASES INCREASED 378 0.0170
347 UROSEPSIS 155 0.0168
348 ORAL DISORDER 123 0.0168
349 FOETAL GROWTH RESTRICTION 102 0.0168
350 HAIR GROWTH ABNORMAL 115 0.0166
351 RHABDOMYOLYSIS 686 0.0164
352 NEUROLOGICAL SYMPTOM 94 0.0164
353 THERAPEUTIC RESPONSE DECREASED 995 0.0164
354 PAPULE 115 0.0163
355 PRODUCT ODOUR ABNORMAL 170 0.0162
356 GAMMA-GLUTAMYLTRANSFERASE INCREASED 359 0.0162
357 CATARACT OPERATION 96 0.0162
358 CATARACT 962 0.0161
359 ENTEROCOLITIS 93 0.0161
360 HYPERTRANSAMINASAEMIA 112 0.0161
361 LIQUID PRODUCT PHYSICAL ISSUE 117 0.0160
362 POLYARTHRITIS 84 0.0159
363 HYPERTENSION 3297 0.0155
364 FEAR OF INJECTION 111 0.0155
365 GLAUCOMA 299 0.0155
366 SYSTEMIC LUPUS ERYTHEMATOSUS 550 0.0155
367 BLOOD ALKALINE PHOSPHATASE INCREASED 383 0.0154
368 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1095 0.0154
369 GLUCOSE TOLERANCE IMPAIRED 91 0.0154
370 VIRAL INFECTION 511 0.0153
371 INFECTION 2221 0.0153
372 DEVICE RELATED INFECTION 236 0.0153
373 PERICARDIAL EFFUSION 354 0.0153
374 AGRANULOCYTOSIS 283 0.0152
375 HEPATOMEGALY 149 0.0151
376 HEPATITIS CHOLESTATIC 91 0.0151
377 AUTOIMMUNE HEPATITIS 105 0.0151
378 HAEMODYNAMIC INSTABILITY 115 0.0151
379 STOMATITIS 910 0.0150
380 PULMONARY FIBROSIS 286 0.0149
381 MOUTH ULCERATION 314 0.0149
382 BLOOD PRESSURE SYSTOLIC INCREASED 289 0.0148
383 RALES 86 0.0148
384 GRAND MAL CONVULSION 136 0.0147
385 TENDONITIS 228 0.0147
386 RENAL FAILURE 1952 0.0147
387 HEPATITIS 375 0.0146
388 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 89 0.0146
389 LYMPHADENOPATHY 517 0.0146
390 TUBULOINTERSTITIAL NEPHRITIS 273 0.0146
391 EYELID PTOSIS 148 0.0145
392 TOXIC EPIDERMAL NECROLYSIS 221 0.0145
393 HEPATIC FAILURE 438 0.0145
394 PLATELET COUNT ABNORMAL 87 0.0144
395 GASTROINTESTINAL INFECTION 129 0.0144
396 RESPIRATORY SYNCYTIAL VIRUS INFECTION 125 0.0143
397 JOINT EFFUSION 98 0.0142
398 PLATELET COUNT INCREASED 185 0.0142
399 ENCEPHALOPATHY 348 0.0142
400 ACUTE RESPIRATORY FAILURE 272 0.0141
401 SHOCK HAEMORRHAGIC 115 0.0141
402 INTERSTITIAL LUNG DISEASE 684 0.0141
403 SKIN HYPERPIGMENTATION 121 0.0141
404 PSORIASIS 1826 0.0140
405 INTRAOCULAR PRESSURE INCREASED 178 0.0139
406 RESPIRATORY DISTRESS 384 0.0139
407 RENAL DISORDER 648 0.0139
408 THROMBOCYTOPENIA 1550 0.0138
409 VASCULITIS 161 0.0138
410 HYPERLIPIDAEMIA 165 0.0138
411 MULTIPLE ALLERGIES 108 0.0138
412 EYE MOVEMENT DISORDER 94 0.0137
413 INSURANCE ISSUE 209 0.0137
414 UVEITIS 185 0.0136
415 PHOTOPSIA 86 0.0136
416 VISUAL ACUITY REDUCED 451 0.0136
417 HAEMATURIA 464 0.0135
418 MALIGNANT MELANOMA 181 0.0135
419 CONJUNCTIVITIS 250 0.0135
420 PRODUCT PACKAGING ISSUE 128 0.0135
421 FOOT DEFORMITY 149 0.0134
422 HELICOBACTER INFECTION 138 0.0134
423 MYOSITIS 120 0.0134
424 GASTROENTERITIS 195 0.0133
425 DUODENAL ULCER PERFORATION 99 0.0133
426 DIALYSIS 188 0.0132
427 ORAL CANDIDIASIS 174 0.0132
428 ASCITES 388 0.0132
429 OSTEOPENIA 200 0.0132
430 HAEMORRHAGE INTRACRANIAL 197 0.0132
431 OEDEMA 714 0.0132
432 END STAGE RENAL DISEASE 239 0.0131
433 ORAL HERPES 255 0.0131
434 PRODUCT DOSE OMISSION IN ERROR 369 0.0130
435 DERMATITIS 273 0.0130
436 EXPIRED PRODUCT ADMINISTERED 433 0.0130
437 ANGIOEDEMA 576 0.0130
438 RHEUMATOID ARTHRITIS 1478 0.0130
439 ACUTE KIDNEY INJURY 1977 0.0129
440 LYMPHOMA 198 0.0128
441 RASH PUSTULAR 93 0.0128
442 HAND DEFORMITY 167 0.0127
443 ARTHRITIS 993 0.0126
444 AUTOIMMUNE DISORDER 123 0.0126
445 PETECHIAE 131 0.0125
446 IMMUNE SYSTEM DISORDER 165 0.0125
447 PYREXIA 4327 0.0125
448 IMPAIRED GASTRIC EMPTYING 169 0.0124
449 HEPATIC ENZYME INCREASED 845 0.0124
450 PHOTOSENSITIVITY REACTION 204 0.0123
451 HEPATIC CIRRHOSIS 232 0.0123
452 DRUG INTERACTION 1956 0.0123
453 ARTHROPATHY 685 0.0123
454 SCRATCH 130 0.0123
455 CELLULITIS 620 0.0123
456 RETINAL DETACHMENT 113 0.0123
457 PLATELET COUNT DECREASED 1309 0.0123
458 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 589 0.0122
459 LARGE INTESTINE PERFORATION 85 0.0122
460 ABSCESS 194 0.0121
461 BLOOD POTASSIUM INCREASED 197 0.0121
462 APHTHOUS ULCER 94 0.0121
463 LUNG INFECTION 187 0.0120
464 HAEMATOCRIT DECREASED 238 0.0120
465 MADAROSIS 139 0.0120
466 PLEURAL EFFUSION 725 0.0119
467 OFF LABEL USE 10421 0.0119
468 DRUG TOXICITY 162 0.0119
469 PRODUCT USE ISSUE 2232 0.0119
470 PRODUCT ADMINISTRATION ERROR 240 0.0119
471 MALNUTRITION 132 0.0118
472 RETINAL HAEMORRHAGE 84 0.0118
473 BLOOD PRESSURE DIASTOLIC DECREASED 87 0.0118
474 CONDITION AGGRAVATED 3582 0.0118
475 PRODUCT ADMINISTRATION INTERRUPTED 92 0.0117
476 ANOREXIA 151 0.0117
477 LEUKOCYTOSIS 211 0.0116
478 THERAPY CESSATION 598 0.0116
479 SKIN DISORDER 388 0.0116
480 DRUG INEFFECTIVE 15318 0.0116
481 LUNG DISORDER 569 0.0116
482 PRODUCT STORAGE ERROR 1016 0.0116
483 ARTHROPOD BITE 86 0.0116
484 CLOSTRIDIUM DIFFICILE INFECTION 253 0.0116
485 BLOOD MAGNESIUM DECREASED 100 0.0116
486 HAEMATOTOXICITY 110 0.0116
487 DIARRHOEA HAEMORRHAGIC 108 0.0115
488 HYPERKALAEMIA 405 0.0115
489 ORAL PAIN 257 0.0115
490 OSTEOPOROSIS 472 0.0115
491 OSTEOMYELITIS 207 0.0114
492 FACIAL PAIN 102 0.0114
493 HYPERTENSIVE CRISIS 127 0.0114
494 RASH PRURITIC 614 0.0113
495 HAEMOGLOBIN DECREASED 1163 0.0113
496 PNEUMOTHORAX 179 0.0113
497 ATELECTASIS 109 0.0113
498 INFUSION RELATED REACTION 745 0.0112
499 RESPIRATORY TRACT INFECTION 291 0.0112
500 FIBROMYALGIA 271 0.0111
501 ACIDOSIS 85 0.0111
502 PNEUMONIA 3596 0.0111
503 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 790 0.0111
504 LIVER DISORDER 492 0.0111
505 PURPURA 98 0.0111
506 PRODUCT DOSE OMISSION 718 0.0110
507 HYPOXIA 387 0.0110
508 RENAL CYST 87 0.0109
509 JAUNDICE 293 0.0109
510 IMMUNODEFICIENCY 162 0.0109
511 VITAMIN D DEFICIENCY 105 0.0108
512 COAGULOPATHY 179 0.0107
513 POOR QUALITY PRODUCT ADMINISTERED 113 0.0107
514 EAR DISCOMFORT 110 0.0107
515 GOUT 192 0.0107
516 WOUND INFECTION 117 0.0107
517 BLOOD PRESSURE INCREASED 1629 0.0106
518 ANAEMIA 2027 0.0106
519 HEPATIC STEATOSIS 197 0.0106
520 UPPER-AIRWAY COUGH SYNDROME 87 0.0105
521 PERICARDITIS 177 0.0105
522 QUALITY OF LIFE DECREASED 141 0.0105
523 UPPER RESPIRATORY TRACT INFECTION 484 0.0105
524 ANKYLOSING SPONDYLITIS 138 0.0105
525 CYSTITIS 333 0.0104
526 BLOOD CREATINE PHOSPHOKINASE INCREASED 301 0.0104
527 GINGIVAL BLEEDING 142 0.0104
528 PULMONARY CONGESTION 137 0.0104
529 DISEASE PROGRESSION 1226 0.0104
530 JOINT SWELLING 1248 0.0103
531 HEPATIC ENCEPHALOPATHY 96 0.0103
532 DIABETES MELLITUS 782 0.0102
533 PHARYNGITIS 127 0.0102
534 OSTEOARTHRITIS 434 0.0102
535 SKIN CANCER 219 0.0102
536 DIPLOPIA 264 0.0102
537 NEUTROPENIA 1381 0.0101
538 URTICARIA 1698 0.0101
539 EYE HAEMORRHAGE 135 0.0101
540 CARDIOMEGALY 124 0.0101
541 ELECTROLYTE IMBALANCE 117 0.0101
542 HYPERSENSITIVITY 1868 0.0101
543 MYOCLONUS 120 0.0101
544 MACULAR DEGENERATION 120 0.0100
545 SUBARACHNOID HAEMORRHAGE 102 0.0100
546 NO THERAPEUTIC RESPONSE 122 0.0100
547 SKIN HAEMORRHAGE 148 0.0100
548 VITAMIN D DECREASED 85 0.0099
549 JOINT RANGE OF MOTION DECREASED 133 0.0099
550 VISUAL IMPAIRMENT 1226 0.0099
551 OSTEONECROSIS 324 0.0099
552 PERITONITIS 204 0.0098
553 LABORATORY TEST ABNORMAL 290 0.0098
554 CHOLECYSTITIS 117 0.0098
555 SECRETION DISCHARGE 123 0.0098
556 ANAPHYLACTIC REACTION 540 0.0098
557 SCIATICA 155 0.0097
558 RASH MACULO-PAPULAR 216 0.0097
559 ILEUS 120 0.0096
560 URINARY TRACT INFECTION 1647 0.0096
561 BURNING SENSATION 677 0.0096
562 SHOCK 222 0.0096
563 DERMATITIS ATOPIC 499 0.0095
564 OESOPHAGITIS 103 0.0094
565 POST PROCEDURAL COMPLICATION 181 0.0094
566 SEASONAL ALLERGY 133 0.0094
567 GASTROINTESTINAL DISORDER 839 0.0094
568 SKIN FISSURES 183 0.0094
569 MUSCULOSKELETAL STIFFNESS 820 0.0094
570 WOUND 261 0.0093
571 SINUSITIS 955 0.0093
572 DERMATITIS CONTACT 106 0.0093
573 SCAB 106 0.0093
574 PEMPHIGUS 116 0.0093
575 NODULE 121 0.0093
576 EAR PAIN 180 0.0092
577 BLOOD CHOLESTEROL INCREASED 431 0.0092
578 IMPAIRED HEALING 302 0.0092
579 JOINT INJURY 196 0.0092
580 PREMATURE DELIVERY 146 0.0092
581 DRUG-INDUCED LIVER INJURY 287 0.0091
582 LIVER FUNCTION TEST INCREASED 196 0.0091
583 CEREBRAL INFARCTION 223 0.0091
584 PERIPHERAL SWELLING 1406 0.0091
585 PAIN OF SKIN 244 0.0091
586 HEMIPARESIS 153 0.0090
587 ALTERED STATE OF CONSCIOUSNESS 195 0.0090
588 PULMONARY MASS 134 0.0090
589 PULMONARY HYPERTENSION 187 0.0090
590 ERYTHEMA 1843 0.0090
591 STATUS EPILEPTICUS 101 0.0089
592 CEREBRAL HAEMORRHAGE 320 0.0089
593 POLYNEUROPATHY 107 0.0089
594 RHINORRHOEA 577 0.0089
595 PRODUCT PRESCRIBING ISSUE 194 0.0089
596 ADRENAL INSUFFICIENCY 108 0.0089
597 MUSCULOSKELETAL DISORDER 169 0.0089
598 MASS 124 0.0089
599 DYSURIA 326 0.0088
600 EPISTAXIS 661 0.0088
601 ALOPECIA 1734 0.0088
602 METABOLIC ACIDOSIS 282 0.0088
603 WHITE BLOOD CELL COUNT INCREASED 338 0.0088
604 MYELOSUPPRESSION 317 0.0088
605 BLOOD PRESSURE FLUCTUATION 211 0.0088
606 DECREASED IMMUNE RESPONSIVENESS 86 0.0088
607 PREMATURE BABY 263 0.0087
608 SINUS CONGESTION 118 0.0087
609 PANCREATITIS ACUTE 196 0.0087
610 RED BLOOD CELL COUNT DECREASED 249 0.0087
611 CAESAREAN SECTION 101 0.0087
612 INFLUENZA 967 0.0087
613 MITRAL VALVE INCOMPETENCE 98 0.0086
614 GASTRIC ULCER 164 0.0086
615 ACNE 652 0.0086
616 ECZEMA 449 0.0086
617 COVID-19 1500 0.0085
618 NECK PAIN 474 0.0085
619 HEPATIC CYTOLYSIS 108 0.0085
620 RESPIRATORY DISORDER 253 0.0084
621 PNEUMONITIS 230 0.0084
622 SNEEZING 189 0.0084
623 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 142 0.0084
624 BODY TEMPERATURE INCREASED 170 0.0083
625 BRONCHITIS 616 0.0083
626 BLOOD TRIGLYCERIDES INCREASED 147 0.0083
627 GASTROENTERITIS VIRAL 150 0.0083
628 CONVULSION 474 0.0083
629 JOINT DISLOCATION 87 0.0082
630 GASTRITIS 216 0.0082
631 LYMPHOCYTE COUNT DECREASED 145 0.0082
632 MYOCARDITIS 94 0.0082
633 BLOOD PRESSURE ABNORMAL 162 0.0081
634 SINUS DISORDER 161 0.0081
635 COLITIS 308 0.0081
636 TRANSFUSION 85 0.0081
637 TACHYPNOEA 110 0.0081
638 CHRONIC KIDNEY DISEASE 611 0.0080
639 ATAXIA 95 0.0080
640 PRURITUS 3068 0.0080
641 ACUTE HEPATIC FAILURE 109 0.0080
642 FLUID OVERLOAD 116 0.0080
643 SWELLING FACE 518 0.0079
644 LIVER INJURY 195 0.0079
645 CARPAL TUNNEL SYNDROME 111 0.0079
646 PRESCRIBED UNDERDOSE 158 0.0079
647 DIVERTICULITIS 218 0.0079
648 CENTRAL NERVOUS SYSTEM LESION 108 0.0079
649 BRAIN FOG 123 0.0078
650 FEEDING DISORDER 159 0.0078
651 ACCIDENTAL EXPOSURE TO PRODUCT 807 0.0078
652 HEPATOCELLULAR INJURY 111 0.0078
653 MELAENA 172 0.0078
654 WHITE BLOOD CELL COUNT DECREASED 845 0.0078
655 OBESITY 124 0.0078
656 PRODUCT PRESCRIBING ERROR 185 0.0078
657 LOCALISED INFECTION 187 0.0077
658 SCAR 132 0.0077
659 ROTATOR CUFF SYNDROME 99 0.0077
660 UPPER LIMB FRACTURE 153 0.0077
661 HEADACHE 4814 0.0077
662 DEPRESSED LEVEL OF CONSCIOUSNESS 301 0.0076
663 OEDEMA PERIPHERAL 920 0.0075
664 SLEEP APNOEA SYNDROME 144 0.0075
665 METASTASES TO LUNG 87 0.0075
666 INTENTIONAL PRODUCT USE ISSUE 659 0.0075
667 BLINDNESS 306 0.0075
668 ABDOMINAL DISCOMFORT 1255 0.0075
669 MIGRAINE 714 0.0075
670 PRODUCTIVE COUGH 356 0.0074
671 EAR INFECTION 198 0.0074
672 SWELLING 696 0.0074
673 ILLNESS 758 0.0074
674 RASH 3204 0.0073
675 HYPOTHYROIDISM 234 0.0073
676 SKIN EXFOLIATION 618 0.0073
677 PRODUCT DOSE OMISSION ISSUE 2149 0.0073
678 DEAFNESS 191 0.0073
679 PULMONARY OEDEMA 327 0.0073
680 CIRCULATORY COLLAPSE 124 0.0073
681 HAEMORRHOIDS 142 0.0073
682 DISCOMFORT 443 0.0073
683 OROPHARYNGEAL PAIN 672 0.0073
684 FACE OEDEMA 122 0.0072
685 CARDIAC FAILURE 576 0.0072
686 MOBILITY DECREASED 515 0.0072
687 ABDOMINAL PAIN 1657 0.0071
688 GASTROINTESTINAL HAEMORRHAGE 595 0.0071
689 DYSPNOEA EXERTIONAL 268 0.0071
690 NERVOUS SYSTEM DISORDER 221 0.0071
691 MUSCULAR WEAKNESS 803 0.0071
692 GENERAL PHYSICAL HEALTH DETERIORATION 817 0.0071
693 TOOTH INFECTION 93 0.0070
694 BLISTER 396 0.0070
695 SKIN DISCOLOURATION 323 0.0070
696 NASAL CONGESTION 413 0.0070
697 MUSCULOSKELETAL PAIN 367 0.0070
698 NASOPHARYNGITIS 1291 0.0070
699 HYPERGLYCAEMIA 253 0.0069
700 MUSCULOSKELETAL DISCOMFORT 119 0.0069
701 ARTHRALGIA 2873 0.0069
702 PAIN IN EXTREMITY 2034 0.0069
703 DIARRHOEA 4422 0.0068
704 CYST 85 0.0068
705 LIP SWELLING 228 0.0068
706 BLOOD SODIUM DECREASED 129 0.0068
707 GLOSSODYNIA 153 0.0068
708 SURGERY 399 0.0068
709 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1216 0.0067
710 PNEUMONIA ASPIRATION 168 0.0067
711 INCORRECT DOSE ADMINISTERED 1533 0.0067
712 HYPOMAGNESAEMIA 93 0.0067
713 HAEMOPTYSIS 186 0.0067
714 COUGH 1861 0.0066
715 NEUTROPHIL COUNT DECREASED 270 0.0066
716 DRY MOUTH 537 0.0066
717 CHILLS 771 0.0066
718 CARDIOGENIC SHOCK 94 0.0065
719 DRUG EXPOSURE DURING PREGNANCY 222 0.0065
720 KIDNEY INFECTION 128 0.0065
721 DYSPHAGIA 617 0.0065
722 MYALGIA 1104 0.0065
723 TREATMENT NONCOMPLIANCE 354 0.0065
724 IMPAIRED QUALITY OF LIFE 93 0.0065
725 HAEMATOMA 167 0.0064
726 CARDIOMYOPATHY 95 0.0064
727 NEURALGIA 156 0.0064
728 SLEEP DISORDER 451 0.0064
729 SKIN REACTION 90 0.0064
730 CHROMATURIA 144 0.0064
731 THROAT IRRITATION 286 0.0064
732 CHOLELITHIASIS 209 0.0064
733 SENSORY DISTURBANCE 102 0.0063
734 GAIT INABILITY 212 0.0063
735 RASH PAPULAR 142 0.0063
736 APHASIA 191 0.0063
737 EJECTION FRACTION DECREASED 98 0.0063
738 STEVENS-JOHNSON SYNDROME 140 0.0063
739 HIP ARTHROPLASTY 96 0.0063
740 MATERNAL EXPOSURE DURING PREGNANCY 558 0.0063
741 HERNIA 121 0.0063
742 ANKLE FRACTURE 96 0.0062
743 MENTAL STATUS CHANGES 172 0.0062
744 ORAL DISCOMFORT 86 0.0062
745 CONTUSION 595 0.0062
746 JOINT STIFFNESS 162 0.0062
747 COLON CANCER 92 0.0062
748 LIMB DISCOMFORT 190 0.0061
749 RASH ERYTHEMATOUS 292 0.0061
750 GALLBLADDER DISORDER 109 0.0061
751 PARAESTHESIA ORAL 88 0.0061
752 RASH MACULAR 213 0.0061
753 APHONIA 85 0.0061
754 OXYGEN SATURATION DECREASED 340 0.0060
755 HEART RATE INCREASED 595 0.0060
756 EMOTIONAL DISORDER 185 0.0060
757 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 154 0.0060
758 WEIGHT DECREASED 1665 0.0060
759 NIGHT SWEATS 192 0.0060
760 BLINDNESS UNILATERAL 84 0.0059
761 PRODUCT AVAILABILITY ISSUE 135 0.0059
762 GASTRIC DISORDER 203 0.0059
763 VOMITING 2780 0.0059
764 FLUID RETENTION 300 0.0059
765 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 101 0.0059
766 TOOTH DISORDER 131 0.0059
767 EOSINOPHILIA 103 0.0059
768 PAIN 3607 0.0059
769 RIB FRACTURE 120 0.0058
770 TREMOR 968 0.0058
771 LIMB INJURY 158 0.0058
772 NAUSEA 4592 0.0058
773 INTENTIONAL DOSE OMISSION 165 0.0058
774 MUSCLE SPASMS 1057 0.0058
775 TOOTHACHE 104 0.0057
776 IRRITABLE BOWEL SYNDROME 123 0.0057
777 ATRIAL FIBRILLATION 555 0.0057
778 PAIN IN JAW 161 0.0057
779 HYPONATRAEMIA 320 0.0057
780 GENERALISED TONIC-CLONIC SEIZURE 94 0.0057
781 NEUROPATHY PERIPHERAL 540 0.0057
782 LOWER RESPIRATORY TRACT INFECTION 257 0.0056
783 ADVERSE DRUG REACTION 507 0.0056
784 BLOOD PRESSURE DECREASED 374 0.0056
785 INSOMNIA 1498 0.0056
786 COLITIS ULCERATIVE 251 0.0056
787 RESPIRATORY TRACT CONGESTION 89 0.0056
788 PANCREATITIS 296 0.0056
789 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 164 0.0056
790 BACK PAIN 1289 0.0055
791 INTERVERTEBRAL DISC PROTRUSION 121 0.0055
792 TASTE DISORDER 112 0.0055
793 DEHYDRATION 735 0.0055
794 DYSPHONIA 322 0.0055
795 FATIGUE 4278 0.0055
796 MENTAL DISORDER 239 0.0055
797 DYSARTHRIA 206 0.0055
798 PRODUCT DISPENSING ERROR 118 0.0054
799 ADVERSE EVENT 499 0.0054
800 TACHYCARDIA 481 0.0054
801 ABDOMINAL PAIN UPPER 1111 0.0054
802 FOOT FRACTURE 102 0.0054
803 GASTROOESOPHAGEAL REFLUX DISEASE 433 0.0054
804 WEIGHT INCREASED 1196 0.0053
805 TINNITUS 245 0.0053
806 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1080 0.0053
807 DYSPEPSIA 522 0.0053
808 SPINAL FRACTURE 106 0.0053
809 ASTHENIA 1988 0.0053
810 HYPOCALCAEMIA 100 0.0053
811 FRACTURE 100 0.0053
812 HYPOKALAEMIA 243 0.0053
813 FULL BLOOD COUNT DECREASED 106 0.0053
814 TYPE 2 DIABETES MELLITUS 177 0.0053
815 ACUTE MYOCARDIAL INFARCTION 155 0.0053
816 EPILEPSY 159 0.0052
817 ABDOMINAL DISTENSION 537 0.0051
818 THERAPEUTIC RESPONSE UNEXPECTED 230 0.0051
819 DISORIENTATION 203 0.0051
820 NEOPLASM MALIGNANT 341 0.0051
821 DYSGEUSIA 379 0.0051
822 MALAISE 2232 0.0051
823 EATING DISORDER 108 0.0051
824 DYSPNOEA 2868 0.0051
825 CORONARY ARTERY DISEASE 153 0.0050
826 DEEP VEIN THROMBOSIS 328 0.0050
827 HYPOAESTHESIA 750 0.0050
828 BLOOD URINE PRESENT 95 0.0050
829 HAEMATOCHEZIA 276 0.0050
830 GAIT DISTURBANCE 957 0.0050
831 SWOLLEN TONGUE 156 0.0050
832 CHEST PAIN 916 0.0049
833 DRY SKIN 658 0.0049
834 POLLAKIURIA 205 0.0049
835 RENAL INJURY 146 0.0049
836 DECREASED APPETITE 1139 0.0049
837 HEAD DISCOMFORT 86 0.0049
838 FAECES DISCOLOURED 105 0.0048
839 ANGINA PECTORIS 138 0.0048
840 HEART RATE DECREASED 169 0.0048
841 COMA 229 0.0048
842 KNEE ARTHROPLASTY 101 0.0048
843 HALLUCINATION, VISUAL 101 0.0048
844 HYPOTENSION 951 0.0047
845 BONE DISORDER 86 0.0047
846 ILL-DEFINED DISORDER 286 0.0047
847 PRODUCT COMPLAINT 119 0.0047
848 URINARY INCONTINENCE 139 0.0047
849 CONFUSIONAL STATE 758 0.0047
850 HAEMORRHAGE 490 0.0047
851 BONE PAIN 274 0.0047
852 TOXICITY TO VARIOUS AGENTS 786 0.0047
853 DISABILITY 92 0.0046
854 PULMONARY EMBOLISM 440 0.0046
855 THERAPEUTIC RESPONSE SHORTENED 153 0.0046
856 POOR QUALITY SLEEP 99 0.0046
857 FALL 1529 0.0046
858 CARDIOVASCULAR DISORDER 116 0.0046
859 SPEECH DISORDER 238 0.0045
860 PARAESTHESIA 714 0.0045
861 VERTIGO 276 0.0045
862 HYPOPHAGIA 115 0.0045
863 INTESTINAL OBSTRUCTION 169 0.0045
864 ARRHYTHMIA 212 0.0045
865 MUSCLE TWITCHING 103 0.0045
866 FEELING ABNORMAL 1069 0.0045
867 HAEMATEMESIS 113 0.0045
868 FEELING HOT 272 0.0044
869 DIZZINESS 2212 0.0044
870 NEPHROLITHIASIS 203 0.0044
871 CARDIAC ARREST 365 0.0044
872 BLOOD POTASSIUM DECREASED 132 0.0044
873 BALANCE DISORDER 378 0.0044
874 COGNITIVE DISORDER 204 0.0044
875 DRUG DOSE OMISSION 719 0.0043
876 WRONG TECHNIQUE IN DRUG USAGE PROCESS 158 0.0043
877 SEIZURE 501 0.0043
878 THROMBOSIS 348 0.0043
879 CYTOKINE RELEASE SYNDROME 86 0.0043
880 RETCHING 91 0.0043
881 CHEST DISCOMFORT 435 0.0042
882 HOT FLUSH 318 0.0042
883 MOVEMENT DISORDER 135 0.0042
884 DELIRIUM 145 0.0042
885 FLATULENCE 236 0.0042
886 ASTHMA 468 0.0041
887 LETHARGY 238 0.0041
888 HIP FRACTURE 133 0.0041
889 HALLUCINATION 311 0.0041
890 HEART RATE IRREGULAR 93 0.0041
891 LOSS OF CONSCIOUSNESS 526 0.0041
892 CONSTIPATION 895 0.0041
893 WHEEZING 243 0.0041
894 ABDOMINAL PAIN LOWER 103 0.0041
895 AGEUSIA 101 0.0040
896 DYSSTASIA 118 0.0040
897 MEMORY IMPAIRMENT 555 0.0040
898 AMNESIA 261 0.0040
899 UNDERDOSE 291 0.0040
900 DEPRESSED MOOD 210 0.0040
901 ACCIDENTAL OVERDOSE 145 0.0040
902 ANAPHYLACTIC SHOCK 101 0.0039
903 FEELING COLD 109 0.0039
904 INJURY 275 0.0039
905 FOETAL EXPOSURE DURING PREGNANCY 315 0.0039
906 ROAD TRAFFIC ACCIDENT 162 0.0039
907 PSYCHOTIC DISORDER 114 0.0039
908 INTENTIONAL PRODUCT MISUSE 337 0.0038
909 THROAT TIGHTNESS 104 0.0038
910 PALPITATIONS 449 0.0038
911 NERVOUSNESS 200 0.0038
912 DEPRESSION 861 0.0038
913 URINARY RETENTION 126 0.0038
914 FREQUENT BOWEL MOVEMENTS 102 0.0038
915 HYPOACUSIS 162 0.0038
916 ANXIETY 1065 0.0037
917 TRANSIENT ISCHAEMIC ATTACK 126 0.0037
918 DISTURBANCE IN ATTENTION 200 0.0037
919 RASH GENERALISED 96 0.0037
920 CARDIAC FAILURE CONGESTIVE 297 0.0037
921 HEAD INJURY 117 0.0037
922 PALLOR 100 0.0037
923 PRESYNCOPE 88 0.0036
924 SOMNOLENCE 726 0.0036
925 SKIN IRRITATION 164 0.0036
926 DEMENTIA 100 0.0036
927 ABASIA 88 0.0036
928 RECTAL HAEMORRHAGE 152 0.0035
929 DRUG EFFECT INCOMPLETE 128 0.0035
930 CRYING 128 0.0035
931 BRADYCARDIA 185 0.0035
932 LUNG NEOPLASM MALIGNANT 143 0.0035
933 EXPOSURE DURING PREGNANCY 216 0.0035
934 INFLUENZA LIKE ILLNESS 283 0.0034
935 UNEVALUABLE EVENT 257 0.0034
936 HYPERSOMNIA 96 0.0033
937 PRODUCT QUALITY ISSUE 451 0.0033
938 SKIN BURNING SENSATION 237 0.0033
939 INTERNATIONAL NORMALISED RATIO INCREASED 94 0.0033
940 PLASMA CELL MYELOMA 127 0.0033
941 CARDIO-RESPIRATORY ARREST 135 0.0032
942 ABORTION SPONTANEOUS 129 0.0032
943 PANIC ATTACK 117 0.0032
944 FEMUR FRACTURE 98 0.0032
945 SYNCOPE 316 0.0032
946 CARDIAC DISORDER 294 0.0031
947 HYPERHIDROSIS 401 0.0031
948 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 162 0.0031
949 DEATH 2566 0.0030
950 MYOCARDIAL INFARCTION 518 0.0030
951 INJECTION SITE REACTION 204 0.0030
952 DRUG ADMINISTRATION ERROR 89 0.0029
953 HYPOGLYCAEMIA 140 0.0029
954 CEREBROVASCULAR ACCIDENT 486 0.0029
955 INJECTION SITE BRUISING 226 0.0028
956 MEDICATION ERROR 155 0.0028
957 DRUG EFFECT DECREASED 150 0.0028
958 AGITATION 198 0.0027
959 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 90 0.0027
960 DYSKINESIA 107 0.0026
961 RESTLESSNESS 96 0.0026
962 IRRITABILITY 157 0.0026
963 HOSPITALISATION 399 0.0026
964 NEOPLASM PROGRESSION 88 0.0025
965 FLUSHING 254 0.0025
966 PRODUCT SUBSTITUTION ISSUE 143 0.0025
967 NIGHTMARE 85 0.0025
968 MALIGNANT NEOPLASM PROGRESSION 250 0.0024
969 EMOTIONAL DISTRESS 290 0.0024
970 INJECTION SITE SWELLING 183 0.0024
971 BLOOD GLUCOSE INCREASED 432 0.0023
972 EXTRA DOSE ADMINISTERED 91 0.0022
973 ABNORMAL BEHAVIOUR 87 0.0022
974 OVERDOSE 470 0.0022
975 SUICIDAL IDEATION 199 0.0022
976 INJECTION SITE PRURITUS 143 0.0021
977 INJECTION SITE PAIN 650 0.0021
978 INJECTION SITE HAEMORRHAGE 163 0.0020
979 VAGINAL HAEMORRHAGE 88 0.0020
980 INJECTION SITE ERYTHEMA 246 0.0020
981 BLOOD GLUCOSE DECREASED 91 0.0019
982 NO ADVERSE EVENT 335 0.0018
983 BREAST CANCER 172 0.0018
984 MULTIPLE SCLEROSIS 86 0.0018
985 DEVICE ISSUE 154 0.0017
986 DEVICE MALFUNCTION 109 0.0015
987 DRUG DEPENDENCE 121 0.0008